During the past decade, Palmetto Retina Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palmetto Retina Center" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Bayer" with 1 trials sponsored, "Greater Houston Retina Research" with 1 trials sponsored and "Kodiak Sciences Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palmetto Retina Center" #1 collaborator was "Clinical Trials Resource Group, LLC" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Palmetto Retina Center" are "Geographic Atrophy" (6 trials), "Diabetic Macular Edema" (5 trials), "Diabetic Retinopathy" (2 trials), "Macular Degeneration, Age-Related" (2 trials) and "Neovascular Age-Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Palmetto Retina Center" in a lesser frequency.

Most popular intervention types in "Palmetto Retina Center" are "Drug" (17 trials), "Other" (7 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials), "Galegenimab" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Palmetto Retina Center" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Palmetto Retina Center". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Palmetto Retina Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Palmetto Retina Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".